AGENDA FOR 2020 MEDINVEST INFECTIOUS DISEASE CONFERENCE
(2021 AGENDA TO BE RELEASED MARCH 20, 2021) 

MONDAY, JUNE 15, 2020

All times are in Eastern Time Zone - USA

8:30am // OPENING REMARKS

8:40am // SPEAKER - DR. LYNDA CHIN (Founder, Department of Genomic Medicine at MD Anderson Cancer Center; Co-Founder & CEO, Apricity Health)                           Topic: Connecting COVID-19 Screening at Workplace with Care and Clinical Trials

9:10am // KEYNOTE TALK -  DR. JEROME KIM (Director General of the International Vaccine Institute)

                   Topic: Developing a Vaccine for COVID-19

09:40am // Corporate Presentation - 4D Pharma

10:00am // Corporate Presentation - Mobidiag

10:20am // Corporate Presentation - Aptorum Group

10:40am // Corporate Presentation - NovaBiotics

11:00am // Corporate Presentation - Moleculera Labs

11:20am // Corporate Presentation - pHion Therapeutics

11:40am // Corporate Presentation - PathoQuest

12:00pm // Corporate Presentation - Primal Therapies
12:20 pm //  Corporate Presentation - Mirror Biologics

12:40 pm //  Corporate Presentation - RedHill Biopharma

01:00 pm // TALK - BRIAN LELYAND-JONES (Director Darwin Institute, CMO NFCR, Frm Director McGill and Emory Cancer Centers)

                       Topic: Managing the Inflammatory Effects of COVID-19 and Managing Clinical Trials in the Era of COVID

01:30 pm // Corporate Presentation - SciTech Development

01:50 pm // Corporate Presentation - Chelation Partners

02:10 pm // Corporate Presentation - SIWA Therapeutics

02:30 pm // Corporate Presentation - Tetra BioPharma

02:50 pm // Corporate Presentation - GATTACO

03:10 pm // Corporate Presentation - Airway Therapeutics

03:30 pm // Corporate Presentation - Ashvattha Therapeutics

03:50 pm // Corporate Presentation - DeepSense Biotechnologies

04:10 pm // Corporate Presentation - 20/20 Gene Systems

04:30 pm // Corporate Presentation - Imago Systems

04:50 pm // SPEAKER - DOUGLAS MONTICCIOLO (Founder, CEO, and CIO of Brevet Capital)

                       Topic: Financing COVID-19 Supplies for Governments and Healthcare Providers While Managing Fraud, Customs, Shipping, and Financial Risk

5:40 pm // CLOSING REMARKS

TUESDAY, JUNE 16, 2020

All times are in Eastern Time Zone - USA

8:30am // OPENING REMARKS

8:40am // KEYNOTE SPEAKER - GEORGE POSTE (Professor, ASU; Former Head of R&D, GSK; Defense Science Board of the U.S. Department of Defense) 

                   Topic: Biosecurity: A Multi-Dimensional Challenge of Escalating Complexity and Urgency

9:10am // SPEAKER - ARTURO CASADEVALL (Chair, Molecular Microbiology & Immunology, Johns Hopkins)

                   Topic: The Use of Convalescent Serum in COVID-19 Treatment

09:40am // Corporate Presentation - NIBEC

10:00am // Corporate Presentation - Phagelux

10:20am // Corporate Presentation - BactoByte

10:40am // Corporate Presentation - Immuni Therapeutics

11:00am // Corporate Presentation - 7 Hills Pharma

11:20am // Corporate Presentation - Weinberg Medical Physics

11:40am // Corporate Presentation - Microbion Corporation

12:00pm // Corporate Presentation - emocha Health
12:20 pm //  Corporate Presentation - Servare Biologics

12:40 pm //  Corporate Presentation - Cofactor Genomics

01:00 pm // SPEAKER - DR. ALFRED SLANETZ (CEO Geneius Biotech, Frm CEO Bluebird Bio, Frm Director Product Development Genetech) 

                       Topic: Developing Cellular Therapies for COVID-19

01:30 pm // Corporate Presentation - Geneius Biotechnology

01:50 pm // Corporate Presentation - Decoy Biosystems

02:10 pm // Corporate Presentation - Thrive Bioscience

02:30 pm // Corporate Presentation - Soligenix

02:50 pm // Corporate Presentation - MaxWell Biosciences

03:10 pm // Corporate Presentation - FZata

03:30 pm // Corporate Presentation - Virion Therapeutics

03:50 pm // Corporate Presentation - Adarza Biosystem

04:10 pm // Corporate Presentation - ChipCare Corporation

04:30 pm // Corporate Presentation - OTraces

04:50 pm // Corporate Presentation - Aphios Corporation

05:10 pm // SPEAKER - DR. WENDY ZIAI (Medical Director, Neurovascular Laboratory, Johns Hopkins; Co-Director, Johns Hopkins Bayview Neurocritical Care Unit)

                      Topic: Managing the Neurological Effects of COVID-19 and Fighting COVID-19 from the Fronts Lines of the ICU

05:40 pm // SPEAKER - DR. ROBERT C. GALLO (Co-Founder and Director, The Institute of Human Virology (IHV) and Co-Founder HIV Virus)

                      Topic: Re-purposing Polio Vaccine in the War Against COVID-19

06:10 pm // SPEAKER - DR. WOLFGANG KLIETMAN (Harvard Medical School)

                      Topic: Vaccines and Biodefense

06:40 pm // CLOSING REMARKS